Teva Pharmaceutical Industries Ltd. — Proxy Solicitation & Information Statement 2005

Jun 22, 2005

C003	��� ������ ��������� ��"�		2
Public	TEVA- PHARMACEUTICAL INDUSTRIES LTD.
	2529	Corporation no: 520013954
	Stock Exchange/Market: ���
	310
	381	P.O.B 3190 , Petach Tikva 49131 , ,
	Tel: 03-9267297 , 03-9267281 Fax: 03-9267429
	E.mail address: DORIT@TEVA.CO.IL	Date of transmission: 22/06/2005
		Time of broadcast: 18:21 17:28:11
		Reference: 2005-02-045321

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Following our annoucement of June 16 2005 regarding the agenda for Teva's AGM, attached please find a copy of our Proxy as filed with the SEC today. In addition, enclosed is a free translation to Hebrew of the Proxy and the Financial Statements for 2004. The 20-F was already filed on 21.3.05

PROXY2005combined_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
Date of revision of form structure: 18/04/2005
- - -
Name of the Signatory : Suesskind Dan Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il